| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
DHANVANTRI JEEVAN REKHA LTD. (BSE: 531043)
531043 Technical Analysis
4
| As on 5th Jul 2024 531043 SHARE Price closed @ 22.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 17.09 & Strong Buy for SHORT-TERM with Stoploss of 19.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
531043SHARE Price
| Open | 20.25 | Change | Price | % |
| High | 22.20 | 1 Day | 0.98 | 4.63 |
| Low | 20.25 | 1 Week | -0.33 | -1.47 |
| Close | 22.15 | 1 Month | 4.43 | 25.00 |
| Volume | 7374 | 1 Year | 10.65 | 92.61 |
| 52 Week High 27.73 | 52 Week Low 10.31 | ||||
BSE INDIA Most Active Stocks
| 512149 | 1.00 | -3.85% |
| 532648 | 26.63 | 11.14% |
| 532775 | 4.15 | 4.80% |
| 532822 | 17.09 | -2.40% |
| 530557 | 1.32 | -4.35% |
| 531752 | 1.76 | 19.73% |
| 509051 | 1.63 | -4.12% |
| 532154 | 1.20 | 4.35% |
| 531025 | 0.94 | -10.48% |
| 532411 | 0.41 | 0.00% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 531043 Daily Charts |
531043 Intraday Charts |
Whats New @ Bazaartrend |
531043 Free Analysis |
|
|
531043 Important Levels Intraday
| RESISTANCE | 25.91 |
| RESISTANCE | 24.70 |
| RESISTANCE | 23.96 |
| RESISTANCE | 23.21 |
| SUPPORT | 21.09 |
| SUPPORT | 20.34 |
| SUPPORT | 19.60 |
| SUPPORT | 18.39 |
531043 Target December 2024
| 4th UP Target | 33.96 |
| 3rd UP Target | 30.28 |
| 2nd UP Target | 28 |
| 1st UP Target | 25.73 |
| 1st DOWN Target | 19.23 |
| 2nd DOWN Target | 16.96 |
| 3rd DOWN Target | 14.68 |
| 4th DOWN Target | 11 |
531043 Weekly Target
| 4th UP Target | 33.66 |
| 3rd UP Target | 30.07 |
| 2nd UP Target | 27.86 |
| 1st UP Target | 25.64 |
| 1st DOWN Target | 19.32 |
| 2nd DOWN Target | 17.10 |
| 3rd DOWN Target | 14.89 |
| 4th DOWN Target | 11.30 |
531043 Target2024
| 4th UP Target | 25.1 |
| 3rd UP Target | 21.46 |
| 2nd UP Target | 19.21 |
| 1st UP Target | 16.96 |
| 1st DOWN Target | 10.54 |
| 2nd DOWN Target | 8.29 |
| 3rd DOWN Target | 6.04 |
| 4th DOWN Target | 2.4 |
DHANVANTRI JEEVAN REKHA LTD. ( BSE INDIA Symbol : 531043 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
531043 Business Profile
Dhanvantri Jeevan Rekha Limited provides medical and health care services in India. The company operates the multi-specialty Dhanvantri hospital in Meerut. Its Dhanvantri Hospital offers diagnostic and therapeutic services, including cardiology, neurology, respiratory medicine, gastroenterology, gastro surgery, neuro surgery, orthopedic surgery, urology, oral and maxillofaccial surgery, oncology, otorhinolaryngology, pathology, rehabilitation program, and other diagnostic services. The company also operates intensive coronary care units and intensive care units. In addition, it offers services for various breast problems, such as mastalgias, mastopathies, breast lumps, and breast cancer, as well as screening for early breast cancers and training for self-examinations. Dhanvantri Jeevan Rekha Limited was founded in 1993 and is based in Meerut, India. Address: No.1, Saket, Meerut, India, 250003
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service